Table 1. Cancer Prevention & Research Institute of Texas' latest grant recipients.

Recipient

Program

Funding ($M)

Companies

 

 

Asuragen Inc.

Mutational profiling of tumors by next-generation DNA sequencing

6.8

Cell Medica Ltd.

Clinical development of T cell therapies

15.6

Kalon Biotherapeutics LLC

Process development and manufacturing of biologics

7.9

Pulmotect Inc.

Clinical development of PUL-042, an inhalable immunomodulatory agent

7.1

Academic institutions

 

 

Houston-Area Translational Research Consortium

Translational research incubator

20

The University of Texas MD Anderson Cancer Center

Targeted breast cancer therapies, cancer pain therapies, immunotherapeutics, imaging and cytometric technology, and staff recruitment

6.7

The University of Texas Southwestern Medical Center

Biomarker studies, and faculty and staff recruitment

5

The University of Texas Health Science Center at Houston

Cancer imaging

0.6

Texas A&M University

Cancer metabolism and faculty recruitment

4

Baylor College of Medicine

Development of molecular diagnostics and cancer vaccines

2

The Methodist Hospital Research Institute

Small interfering RNA therapeutics for breast cancer and immunomodulatory therapies for prostate cancer

1.9

Texas Tech University Health Science Center

Preclinical development and manufacturing of a ceramide catabolism inhibitor to treat solid tumors

1

Texas A&M University Health Science Center

Cancer metabolism

1.5

The University of Texas Health Science Center at San Antonio

NMR facility for drug discovery

1